Juan Duchesne, Bryant J McLafferty, Jacob M Broome, Sydney Caputo, Joseph P Ritondale, Danielle Tatum, Sharven Taghavi, Olan Jackson-Weaver, Sherman Tran, Patrick McGrew, Kevin N Harrell, Alison Smith, Emily Nichols, Thomas Dransfield, Megan Marino, Mark Piehl
INTRODUCTION: Prehospital resuscitation with blood products is gaining popularity for patients with traumatic hemorrhage. The MEDEVAC trial demonstrated a survival benefit exclusively among patients who received blood or plasma within 15 minutes of air medical evacuation. In fast-paced urban EMS systems with a high incidence of penetrating trauma, mortality data based on the timing to first blood administration is scarce. We hypothesize a survival benefit in patients with severe hemorrhage when blood is administered within the first 15 minutes of EMS patient contact...
May 1, 2024: Journal of Trauma and Acute Care Surgery